Solventum (SOLV) Research & Development (2023 - 2026)

Solventum has reported Research & Development for 4 years, with the latest figure at $189.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 2.07% year-over-year to $189.0 million; the trailing twelve-month figure through Mar 2026 stood at $736.0 million (down 4.79% YoY), and the FY2025 full-year result was $739.0 million, down 4.65% from the prior year.
• Research & Development for Q1 2026 stood at $189.0 million, up from $175.0 million in the prior quarter.
• The five-year high for Research & Development was $199.0 million in Q4 2024, with the low at $175.0 million in Q4 2025.
• Historically, Research & Development has averaged $189.4 million across 4 years, with a median of $190.0 million in 2023.
• Annual changes were most pronounced in 2024 — Research & Development climbed 5.0% — and 2025, when it declined 12.06%.
• Solventum's Research & Development stood at $190.0 million in 2023, then increased by 4.74% to $199.0 million in 2024, then decreased by 12.06% to $175.0 million in 2025, then advanced by 8.0% to $189.0 million in 2026.
• The last three Research & Development figures came in at $189.0 million (Q1 2026), $175.0 million (Q4 2025), and $183.0 million (Q3 2025), per Business Quant data.